Research and Markets: Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/606282/active_pharmaceuti) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases" report to their offering.

“Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases”

Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases provides detailed insight into the Asia-Pacific API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the Asia-Pacific API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Asia-Pacific API Market is Set to Grow at a Faster Rate in the Forecast Period

Asia-Pacific is the third largest regional market for APIs by revenue in the world after North America and Europe. The region is the fastest growing API market in the world. The Asia-Pacific API market grew consistently at a Compound Annual Growth Rate (CAGR) of 6.7% from 2005 to 2010. The year-on-year growth rate also increased continuously in this period. It is expected to witness an even higher growth rate in the forecast period. The Asia-Pacific API market's revenues will grow at a CAGR of 9.6% from 2010 to 2016. The Generic Sector Dominates the Asia-Pacific API Market

The generic sector is the dominating one in Asia-Pacific region. The generic APIs held a share of 71.5% in the region's API revenue in 2010, while innovator APIs held a share of 28.5%. The share of innovator sector APIs is higher in Japan and lower in China and India.

Japan is the largest Market for APIs followed by China in Asia-Pacific Region

Japan is the largest market for APIs in the Asia-Pacific region. Japan contributed 42.8% of the region's total API market revenues. China is the second largest and the fastest growing API market in Asia-Pacific. China currently holds a share of 20.8% in the region's total API market revenues. India is the third largest API market in the region accounting for a share of 10.3%. South Korea is another important API market in Asia-Pacific, accounting for a share of 8.1% in the region's total API market revenues.

Scope

• API markets in key countries in the region: Japan, China, India and South Korea.
• API industry structure and market trends such as a shift in manufacturing and growth in biotechnology for the Asia-Pacific region.
• Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the region's key countries.
• Information on the competitive landscape, with shares of leading companies such as Pfizer Inc, AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Sanofi-Aventis and Novartis.
• Analysis of API revenue based on product types in the Asia-Pacific market and in key countries of the region.
• Analysis of API revenue based on therapeutic categories in the key countries.

Key Topics Covered:

1 Tables of Contents

2 Introduction

3 Asia-Pacific API Market

4 Japan API Market

5 China API Market

6 India API Market

7 South Korea API Market

For more information visit http://www.researchandmarkets.com/research/606282/active_pharmaceuti